Rikke Linnemann Nielsen, Thomas Monfeuga, Robert R Kitchen, Line Egerod, Luis G Leal, August Thomas Hjortshøj Schreyer, Frederik Steensgaard Gade, Carol Sun, Marianne Helenius, Lotte Simonsen, Marianne Willert, Abd A Tahrani, Zahra McVey, Ramneek Gupta
Osteoarthritis (OA) is increasing in prevalence and has a severe impact on patients' lives. However, our understanding of biomarkers driving OA risk remains limited. We developed a model predicting the five-year risk of OA diagnosis, integrating retrospective clinical, lifestyle and biomarker data from the UK Biobank (19,120 patients with OA, ROC-AUC: 0.72, 95%CI (0.71-0.73)). Higher age, BMI and prescription of non-steroidal anti-inflammatory drugs contributed most to increased OA risk prediction ahead of diagnosis...
April 1, 2024: Nature Communications